The effects of phosphatidylserine on endocrine response to moderate intensity exercise View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-01-03

AUTHORS

Michael A Starks, Stacy L Starks, Michael Kingsley, Martin Purpura, Ralf Jäger

ABSTRACT

BackgroundPrevious research has indicated that phosphatidylserine (PS) supplementation has the potential to attenuate the serum cortisol response to acute exercise stress. Equivocal findings suggest that this effect might be dose dependent. This study aimed to examine the influence of short-term supplementation with a moderate dose of PS (600 mg per day) on plasma concentrations of cortisol, lactate, growth hormone and testosterone before, during, and following moderate intensity exercise in healthy males.Methods10 healthy male subjects participated in the study. Each subject was assigned to ingest 600 mg PS or placebo per day for 10 days using a double-blind, placebo-controlled, crossover design. Serial venous blood samples were taken at rest, after a 15 minute moderate intensity exercise protocol on a cycle ergometer that consisted of five 3-minute incremental stages beginning at 65% and ending at 85% VO2 max, and during a 65 minute passive recovery. Plasma samples were assessed for cortisol, growth hormone, testosterone, lactate and testosterone to cortisol ratio for treatment (PS or placebo).ResultsMean peak cortisol concentrations and area under the curve (AUC) were lower following PS (39 ± 1% and 35 ± 0%, respectively) when compared to placebo (p < 0.05). PS increased AUC for testosterone to cortisol ratio (184 ± 5%) when compared to placebo (p < 0.05). PS and placebo supplementation had no effect on lactate or growth hormone levels.ConclusionThe findings suggest that PS is an effective supplement for combating exercise-induced stress and preventing the physiological deterioration that can accompany too much exercise. PS supplementation promotes a desired hormonal status for athletes by blunting increases in cortisol levels. More... »

PAGES

11

References to SciGraph publications

  • 1988-08. Overtraining in Elite Athletes in SPORTS MEDICINE
  • 2007-07-13. The effect of phosphatidylserine on golf performance in JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION
  • 1989-10. Serum hormone concentrations during prolonged training in elite endurance-trained and strength-trained athletes in EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY
  • 1992-04. Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2007-07-13. Phospholipids and sports performance in JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION
  • 1997-02. Resistance Exercise Overtraining and Overreaching in SPORTS MEDICINE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/1550-2783-5-11

    DOI

    http://dx.doi.org/10.1186/1550-2783-5-11

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1023906670

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/18662395


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "The University of Mississippi, 215 Turner, University, 38655, MS, USA", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "The University of Mississippi, 215 Turner, University, 38655, MS, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Starks", 
            "givenName": "Michael A", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The University of Mississippi, 215 Turner, University, 38655, MS, USA", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "The University of Mississippi, 215 Turner, University, 38655, MS, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Starks", 
            "givenName": "Stacy L", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Swansea University, Singleton Park, Swansea, SA2 8PP, UK", 
              "id": "http://www.grid.ac/institutes/grid.4827.9", 
              "name": [
                "Swansea University, Singleton Park, Swansea, SA2 8PP, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kingsley", 
            "givenName": "Michael", 
            "id": "sg:person.0764727325.11", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764727325.11"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Increnovo LLC, 2138 E Lafayette Pl, Milwaukee, 53202, WI, USA", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Increnovo LLC, 2138 E Lafayette Pl, Milwaukee, 53202, WI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Purpura", 
            "givenName": "Martin", 
            "id": "sg:person.0647320012.70", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647320012.70"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Increnovo LLC, 2138 E Lafayette Pl, Milwaukee, 53202, WI, USA", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Increnovo LLC, 2138 E Lafayette Pl, Milwaukee, 53202, WI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "J\u00e4ger", 
            "givenName": "Ralf", 
            "id": "sg:person.01165612516.84", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165612516.84"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/bf02386193", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031868069", 
              "https://doi.org/10.1007/bf02386193"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00280123", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1075583293", 
              "https://doi.org/10.1007/bf00280123"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00007256-198806020-00003", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023099174", 
              "https://doi.org/10.2165/00007256-198806020-00003"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1550-2783-4-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023481107", 
              "https://doi.org/10.1186/1550-2783-4-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00007256-199723020-00004", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036058734", 
              "https://doi.org/10.2165/00007256-199723020-00004"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1550-2783-4-23", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033339128", 
              "https://doi.org/10.1186/1550-2783-4-23"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2008-01-03", 
        "datePublishedReg": "2008-01-03", 
        "description": "BackgroundPrevious research has indicated that phosphatidylserine (PS) supplementation has the potential to attenuate the serum cortisol response to acute exercise stress. Equivocal findings suggest that this effect might be dose dependent. This study aimed to examine the influence of short-term supplementation with a moderate dose of PS (600 mg per day) on plasma concentrations of cortisol, lactate, growth hormone and testosterone before, during, and following moderate intensity exercise in healthy males.Methods10 healthy male subjects participated in the study. Each subject was assigned to ingest 600 mg PS or placebo per day for 10 days using a double-blind, placebo-controlled, crossover design. Serial venous blood samples were taken at rest, after a 15 minute moderate intensity exercise protocol on a cycle ergometer that consisted of five 3-minute incremental stages beginning at 65% and ending at 85% VO2 max, and during a 65 minute passive recovery. Plasma samples were assessed for cortisol, growth hormone, testosterone, lactate and testosterone to cortisol ratio for treatment (PS or placebo).ResultsMean peak cortisol concentrations and area under the curve (AUC) were lower following PS (39 \u00b1 1% and 35 \u00b1 0%, respectively) when compared to placebo (p < 0.05). PS increased AUC for testosterone to cortisol ratio (184 \u00b1 5%) when compared to placebo (p < 0.05). PS and placebo supplementation had no effect on lactate or growth hormone levels.ConclusionThe findings suggest that PS is an effective supplement for combating exercise-induced stress and preventing the physiological deterioration that can accompany too much exercise. PS supplementation promotes a desired hormonal status for athletes by blunting increases in cortisol levels.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/1550-2783-5-11", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1034609", 
            "issn": [
              "1550-2783"
            ], 
            "name": "Journal of the International Society of Sports Nutrition", 
            "publisher": "Taylor & Francis", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "5"
          }
        ], 
        "keywords": [
          "moderate-intensity exercise", 
          "intensity exercise", 
          "growth hormone", 
          "Serial venous blood samples", 
          "venous blood samples", 
          "short-term supplementation", 
          "acute exercise stress", 
          "growth hormone levels", 
          "exercise-induced stress", 
          "healthy male subjects", 
          "peak cortisol concentrations", 
          "serum cortisol response", 
          "phosphatidylserine supplementation", 
          "PS supplementation", 
          "placebo supplementation", 
          "exercise protocol", 
          "plasma concentrations", 
          "hormone levels", 
          "exercise stress", 
          "healthy males", 
          "moderate dose", 
          "hormonal status", 
          "endocrine responses", 
          "blood samples", 
          "cortisol response", 
          "crossover design", 
          "cortisol levels", 
          "cycle ergometer", 
          "effect of phosphatidylserine", 
          "male subjects", 
          "cortisol concentrations", 
          "placebo", 
          "VO2 max", 
          "passive recovery", 
          "equivocal findings", 
          "testosterone", 
          "supplementation", 
          "plasma samples", 
          "BackgroundPrevious research", 
          "cortisol", 
          "dose", 
          "hormone", 
          "exercise", 
          "physiological deterioration", 
          "lactate", 
          "subjects", 
          "days", 
          "effective supplement", 
          "findings", 
          "ergometer", 
          "response", 
          "AUC", 
          "incremental stages", 
          "treatment", 
          "levels", 
          "athletes", 
          "effect", 
          "males", 
          "study", 
          "supplements", 
          "status", 
          "concentration", 
          "deterioration", 
          "rest", 
          "stress", 
          "samples", 
          "phosphatidylserine", 
          "recovery", 
          "protocol", 
          "ratio", 
          "increase", 
          "stage", 
          "potential", 
          "curves", 
          "area", 
          "max", 
          "PS", 
          "research", 
          "influence", 
          "design"
        ], 
        "name": "The effects of phosphatidylserine on endocrine response to moderate intensity exercise", 
        "pagination": "11", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1023906670"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/1550-2783-5-11"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "18662395"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/1550-2783-5-11", 
          "https://app.dimensions.ai/details/publication/pub.1023906670"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-05-20T07:24", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_458.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/1550-2783-5-11"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1550-2783-5-11'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1550-2783-5-11'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1550-2783-5-11'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1550-2783-5-11'


     

    This table displays all metadata directly associated to this object as RDF triples.

    196 TRIPLES      22 PREDICATES      112 URIs      98 LITERALS      7 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/1550-2783-5-11 schema:about anzsrc-for:11
    2 anzsrc-for:1103
    3 schema:author N40503ea8e6ec483aa28faeb51f424ba3
    4 schema:citation sg:pub.10.1007/bf00280123
    5 sg:pub.10.1007/bf02386193
    6 sg:pub.10.1186/1550-2783-4-23
    7 sg:pub.10.1186/1550-2783-4-5
    8 sg:pub.10.2165/00007256-198806020-00003
    9 sg:pub.10.2165/00007256-199723020-00004
    10 schema:datePublished 2008-01-03
    11 schema:datePublishedReg 2008-01-03
    12 schema:description BackgroundPrevious research has indicated that phosphatidylserine (PS) supplementation has the potential to attenuate the serum cortisol response to acute exercise stress. Equivocal findings suggest that this effect might be dose dependent. This study aimed to examine the influence of short-term supplementation with a moderate dose of PS (600 mg per day) on plasma concentrations of cortisol, lactate, growth hormone and testosterone before, during, and following moderate intensity exercise in healthy males.Methods10 healthy male subjects participated in the study. Each subject was assigned to ingest 600 mg PS or placebo per day for 10 days using a double-blind, placebo-controlled, crossover design. Serial venous blood samples were taken at rest, after a 15 minute moderate intensity exercise protocol on a cycle ergometer that consisted of five 3-minute incremental stages beginning at 65% and ending at 85% VO2 max, and during a 65 minute passive recovery. Plasma samples were assessed for cortisol, growth hormone, testosterone, lactate and testosterone to cortisol ratio for treatment (PS or placebo).ResultsMean peak cortisol concentrations and area under the curve (AUC) were lower following PS (39 ± 1% and 35 ± 0%, respectively) when compared to placebo (p < 0.05). PS increased AUC for testosterone to cortisol ratio (184 ± 5%) when compared to placebo (p < 0.05). PS and placebo supplementation had no effect on lactate or growth hormone levels.ConclusionThe findings suggest that PS is an effective supplement for combating exercise-induced stress and preventing the physiological deterioration that can accompany too much exercise. PS supplementation promotes a desired hormonal status for athletes by blunting increases in cortisol levels.
    13 schema:genre article
    14 schema:inLanguage en
    15 schema:isAccessibleForFree true
    16 schema:isPartOf N3d3a1a127ace438fb05486018dcd0a65
    17 N869ac86451c043c2b8ee57df4a7175cb
    18 sg:journal.1034609
    19 schema:keywords AUC
    20 BackgroundPrevious research
    21 PS
    22 PS supplementation
    23 Serial venous blood samples
    24 VO2 max
    25 acute exercise stress
    26 area
    27 athletes
    28 blood samples
    29 concentration
    30 cortisol
    31 cortisol concentrations
    32 cortisol levels
    33 cortisol response
    34 crossover design
    35 curves
    36 cycle ergometer
    37 days
    38 design
    39 deterioration
    40 dose
    41 effect
    42 effect of phosphatidylserine
    43 effective supplement
    44 endocrine responses
    45 equivocal findings
    46 ergometer
    47 exercise
    48 exercise protocol
    49 exercise stress
    50 exercise-induced stress
    51 findings
    52 growth hormone
    53 growth hormone levels
    54 healthy male subjects
    55 healthy males
    56 hormonal status
    57 hormone
    58 hormone levels
    59 increase
    60 incremental stages
    61 influence
    62 intensity exercise
    63 lactate
    64 levels
    65 male subjects
    66 males
    67 max
    68 moderate dose
    69 moderate-intensity exercise
    70 passive recovery
    71 peak cortisol concentrations
    72 phosphatidylserine
    73 phosphatidylserine supplementation
    74 physiological deterioration
    75 placebo
    76 placebo supplementation
    77 plasma concentrations
    78 plasma samples
    79 potential
    80 protocol
    81 ratio
    82 recovery
    83 research
    84 response
    85 rest
    86 samples
    87 serum cortisol response
    88 short-term supplementation
    89 stage
    90 status
    91 stress
    92 study
    93 subjects
    94 supplementation
    95 supplements
    96 testosterone
    97 treatment
    98 venous blood samples
    99 schema:name The effects of phosphatidylserine on endocrine response to moderate intensity exercise
    100 schema:pagination 11
    101 schema:productId N54df30834a0d4e4f8a45eb134eb70b62
    102 Nde5a2b564d874b86af62b2928758c65a
    103 Ne02f8f39e94b4ac29060715fa530d633
    104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023906670
    105 https://doi.org/10.1186/1550-2783-5-11
    106 schema:sdDatePublished 2022-05-20T07:24
    107 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    108 schema:sdPublisher N1258ee977e774e8da4a5310819943213
    109 schema:url https://doi.org/10.1186/1550-2783-5-11
    110 sgo:license sg:explorer/license/
    111 sgo:sdDataset articles
    112 rdf:type schema:ScholarlyArticle
    113 N1258ee977e774e8da4a5310819943213 schema:name Springer Nature - SN SciGraph project
    114 rdf:type schema:Organization
    115 N16003e7d92844345b75c5fe35fbfde4c schema:affiliation grid-institutes:None
    116 schema:familyName Starks
    117 schema:givenName Michael A
    118 rdf:type schema:Person
    119 N3cb1a3e0af9e43aca44dbd5ac1e6366b rdf:first sg:person.0647320012.70
    120 rdf:rest N501473896ee94891b837357b0a2de194
    121 N3d3a1a127ace438fb05486018dcd0a65 schema:volumeNumber 5
    122 rdf:type schema:PublicationVolume
    123 N40503ea8e6ec483aa28faeb51f424ba3 rdf:first N16003e7d92844345b75c5fe35fbfde4c
    124 rdf:rest N7aa45e405ad746c28c1bc6ef6f874d89
    125 N501473896ee94891b837357b0a2de194 rdf:first sg:person.01165612516.84
    126 rdf:rest rdf:nil
    127 N54df30834a0d4e4f8a45eb134eb70b62 schema:name dimensions_id
    128 schema:value pub.1023906670
    129 rdf:type schema:PropertyValue
    130 N77c07b08bc024cba8e8e42bfd5280e7a schema:affiliation grid-institutes:None
    131 schema:familyName Starks
    132 schema:givenName Stacy L
    133 rdf:type schema:Person
    134 N7aa45e405ad746c28c1bc6ef6f874d89 rdf:first N77c07b08bc024cba8e8e42bfd5280e7a
    135 rdf:rest Nceaf6c6636df496a81ea0194f688567a
    136 N869ac86451c043c2b8ee57df4a7175cb schema:issueNumber 1
    137 rdf:type schema:PublicationIssue
    138 Nceaf6c6636df496a81ea0194f688567a rdf:first sg:person.0764727325.11
    139 rdf:rest N3cb1a3e0af9e43aca44dbd5ac1e6366b
    140 Nde5a2b564d874b86af62b2928758c65a schema:name doi
    141 schema:value 10.1186/1550-2783-5-11
    142 rdf:type schema:PropertyValue
    143 Ne02f8f39e94b4ac29060715fa530d633 schema:name pubmed_id
    144 schema:value 18662395
    145 rdf:type schema:PropertyValue
    146 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    147 schema:name Medical and Health Sciences
    148 rdf:type schema:DefinedTerm
    149 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    150 schema:name Clinical Sciences
    151 rdf:type schema:DefinedTerm
    152 sg:journal.1034609 schema:issn 1550-2783
    153 schema:name Journal of the International Society of Sports Nutrition
    154 schema:publisher Taylor & Francis
    155 rdf:type schema:Periodical
    156 sg:person.01165612516.84 schema:affiliation grid-institutes:None
    157 schema:familyName Jäger
    158 schema:givenName Ralf
    159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165612516.84
    160 rdf:type schema:Person
    161 sg:person.0647320012.70 schema:affiliation grid-institutes:None
    162 schema:familyName Purpura
    163 schema:givenName Martin
    164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647320012.70
    165 rdf:type schema:Person
    166 sg:person.0764727325.11 schema:affiliation grid-institutes:grid.4827.9
    167 schema:familyName Kingsley
    168 schema:givenName Michael
    169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764727325.11
    170 rdf:type schema:Person
    171 sg:pub.10.1007/bf00280123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075583293
    172 https://doi.org/10.1007/bf00280123
    173 rdf:type schema:CreativeWork
    174 sg:pub.10.1007/bf02386193 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031868069
    175 https://doi.org/10.1007/bf02386193
    176 rdf:type schema:CreativeWork
    177 sg:pub.10.1186/1550-2783-4-23 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033339128
    178 https://doi.org/10.1186/1550-2783-4-23
    179 rdf:type schema:CreativeWork
    180 sg:pub.10.1186/1550-2783-4-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023481107
    181 https://doi.org/10.1186/1550-2783-4-5
    182 rdf:type schema:CreativeWork
    183 sg:pub.10.2165/00007256-198806020-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023099174
    184 https://doi.org/10.2165/00007256-198806020-00003
    185 rdf:type schema:CreativeWork
    186 sg:pub.10.2165/00007256-199723020-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036058734
    187 https://doi.org/10.2165/00007256-199723020-00004
    188 rdf:type schema:CreativeWork
    189 grid-institutes:None schema:alternateName Increnovo LLC, 2138 E Lafayette Pl, Milwaukee, 53202, WI, USA
    190 The University of Mississippi, 215 Turner, University, 38655, MS, USA
    191 schema:name Increnovo LLC, 2138 E Lafayette Pl, Milwaukee, 53202, WI, USA
    192 The University of Mississippi, 215 Turner, University, 38655, MS, USA
    193 rdf:type schema:Organization
    194 grid-institutes:grid.4827.9 schema:alternateName Swansea University, Singleton Park, Swansea, SA2 8PP, UK
    195 schema:name Swansea University, Singleton Park, Swansea, SA2 8PP, UK
    196 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...